Proteomic profiling of platelet signalling

References

• Herr AB, Farndale RW. Structural insights into the interactions between platelet receptors and fibrillar collagen. J. Biol. Chem. 284(30), 19781–19785 (2009).
   PubMed Web of Science ®Google Scholar
• Luo GP, Ni B, Yang X, Wu YZ. von Willebrand factor: more than a regulator of hemostasis and thrombosis. Acta. Haematol. 128(3), 158–169 (2012).
   PubMed Web of Science ®Google Scholar
• Chen J, Lopez JA. Interactions of platelets with subendothelium and endothelium. Microcirculation 12(3), 235–246 (2005).
   PubMed Web of Science ®Google Scholar
• Cruz MA, Chen J, Whitelock JL, Morales LD, Lopez JA. The platelet glycoprotein Ib-von Willebrand factor interaction activates the collagen receptor alpha2beta1 to bind collagen: activation-dependent conformational change of the alpha2-I domain. Blood 105(5), 1986–1991 (2005).
   Google Scholar
• Nieswandt B, Pleines I, Bender M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J. Thromb. Haemost. 9(Suppl. 1), 92–104 (2011).
   PubMed Web of Science ®Google Scholar
• Li Z, Delaney MK, O'Brien KA, Du X. Signaling during platelet adhesion and activation. Arterioscler Thromb. Vasc. Biol. 30(12), 2341–2349 (2010).
   PubMed Web of Science ®Google Scholar
• Coughlin SR, Camerer E. PARticipation in inflammation. J. Clin. Invest. 111(1), 25–27 (2003).
   PubMed Web of Science ®Google Scholar
• Stegner D, Nieswandt B. Platelet receptor signaling in thrombus formation. J. Mol. Med. (Berl.) 89(2), 109–121 (2011).
   PubMed Web of Science ®Google Scholar
• Schweigel H, Geiger J, Beck F et al. Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling. Proteomics 13(6), 1016–1027 (2013).
   PubMed Web of Science ®Google Scholar
• Jennings LK. Role of platelets in atherothrombosis. Am. J. Cardiol. 103(3 Suppl.), 4A–10A (2009).
   PubMed Web of Science ®Google Scholar
• Zufferey A, Fontana P, Reny JL, Nolli S, Sanchez JC. Platelet proteomics. Mass Spectrom Rev. 31(2), 331–351 (2012).
   PubMed Web of Science ®Google Scholar
• Yates JR, Ruse CI, Nakorchevsky A. Proteomics by mass spectrometry: approaches, advances, and applications. Annu. Rev. Biomed. Eng. 11, 49–79 (2009).
   PubMed Web of Science ®Google Scholar
• Ng EW, Wong MY, Poon TC. Advances in MALDI mass spectrometry in clinical diagnostic applications. Top Curr. Chem. doi:10.1007/128_2012_413 (2013) (Epub ahead of print).
   Google Scholar
• Switzar L, Giera M, Niessen WM. Protein digestion: an overview of the available techniques and recent developments. J. Proteome Res. 12(3), 1067–1077 (2013).
   PubMed Web of Science ®Google Scholar
• Ali-Khan N, Zuo X, Speicher DW. Overview of proteome analysis. Curr. Protoc. Protein Sci. Chapter 22, Unit 22 21 (2003).
   Google Scholar
• Brewis IA, Brennan P. Proteomics technologies for the global identification and quantification of proteins. Adv. Protein Chem. Struct. Biol. 80, 1–44 (2010).
   PubMed Web of Science ®Google Scholar
• Wasinger VC, Zeng M, Yau Y. Current status and advances in quantitative proteomic mass spectrometry. Int. J. Proteomics 2013, 180605 (2013).
   PubMedGoogle Scholar
• Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. Bioanal. Chem. 382(3), 669–678 (2005).
   PubMed Web of Science ®Google Scholar
• Weiss W, Gorg A. High-resolution two-dimensional electrophoresis. Methods Mol. Biol. 564, 13–32 (2009).
   Google Scholar
• Rogne M, Tasken K. Cell signalling analyses in the functional genomics era. N. Biotechnol. 30(3), 333–338 (2013).
   Google Scholar
• Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 409(6822), 860–921 (2001).
   PubMed Web of Science ®Google Scholar
• Choudhary C, Mann M. Decoding signalling networks by mass spectrometry-based proteomics. Nat. Rev. Mol. Cell Biol. 11(6), 427–439 (2010).
   PubMed Web of Science ®Google Scholar
• Hu J, Rho HS, Newman RH et al. Global analysis of phosphorylation networks in humans. Biochim. Biophys. Acta. doi:10.1016/j.bbapap.2013.03.009 (2013) (Epub ahead of print).
   Google Scholar
• Ngounou Wetie AG, Sokolowska I, Woods AG, Roy U, Deinhardt K, Darie CC. Protein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches. Cell Mol. Life Sci. doi:10.1007/s00018-013-1333-1 (2013) (Epub ahead of print).
   Google Scholar
• Fila J, Honys D. Enrichment techniques employed in phosphoproteomics. Amino Acids 43(3), 1025–1047 (2012).
   PubMed Web of Science ®Google Scholar
• Engholm-Keller K, Larsen MR. Technologies and challenges in large-scale phosphoproteomics. Proteomics 13(6), 910–931 (2013).
   PubMed Web of Science ®Google Scholar
• Kaneko T, Joshi R, Feller SM, Li SS. Phosphotyrosine recognition domains: the typical, the atypical and the versatile. Cell Commun. Signal 10(1), 32 (2012).
   Google Scholar
• Dierck K, Machida K, Voigt A et al. Quantitative multiplexed profiling of cellular signaling networks using phosphotyrosine-specific DNA-tagged SH2 domains. Nat. Methods 3(9), 737–744 (2006).
   PubMedGoogle Scholar
• Machida K, Thompson CM, Dierck K et al. High-throughput phosphotyrosine profiling using SH2 domains. Mol. Cell 26(6), 899–915 (2007).
   PubMedGoogle Scholar
• Di Michele M, Van Geet C, Freson K. Recent advances in platelet proteomics. Expert Rev. Proteomics 9(4), 451–466 (2012).
   PubMed Web of Science ®Google Scholar
• Schulz C, Leuschen NV, Frohlich T et al. Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Blood 115(20), 4102–4110 (2010).
   PubMed Web of Science ®Google Scholar
• Kaiser WJ, Holbrook LM, Tucker KL, Stanley RG, Gibbins JM. A functional proteomic method for the enrichment of peripheral membrane proteins reveals the collagen binding protein Hsp47 is exposed on the surface of activated human platelets. J. Proteome Res. 8(6), 2903–2914 (2009).
   PubMed Web of Science ®Google Scholar
• Smethurst PA, Onley DJ, Jarvis GE et al. Structural basis for the platelet-collagen interaction: the smallest motif within collagen that recognizes and activates platelet glycoprotein VI contains two glycine-proline-hydroxyproline triplets. J. Biol. Chem. 282(2), 1296–1304 (2007).
   PubMed Web of Science ®Google Scholar
• Garcia A, Senis YA, Antrobus R et al. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 6(19), 5332–5343 (2006).
   PubMed Web of Science ®Google Scholar
• Wright B, Stanley RG, Kaiser WJ, Mills DJ, Gibbins JM. Analysis of protein networks in resting and collagen receptor (GPVI)-stimulated platelet sub-proteomes. Proteomics 11(23), 4588–4592 (2011).
   PubMed Web of Science ®Google Scholar
• Tucker RP, Chiquet-Ehrismann R. Teneurins: a conserved family of transmembrane proteins involved in intercellular signaling during development. Dev. Biol. 290(2), 237–245 (2006).
   Google Scholar
• Kalabis J, Rosenberg I, Podolsky DK. Vangl1 protein acts as a downstream effector of intestinal trefoil factor (ITF)/TFF3 signaling and regulates wound healing of intestinal epithelium. J. Biol. Chem. 281(10), 6434–6441 (2006).
   PubMed Web of Science ®Google Scholar
• Shikata Y, Birukov KG, Birukova AA, Verin A, Garcia JG. Involvement of site-specific FAK phosphorylation in sphingosine-1 phosphate- and thrombin-induced focal adhesion remodeling: role of Src and GIT. FASEB J. 17(15), 2240–2249 (2003).
   PubMed Web of Science ®Google Scholar
• Zahradka P, Storie B, Wright B. IGF-1 receptor transactivation mediates Src-dependent cortactin phosphorylation in response to angiotensin II. Can. J. Physiol. Pharmacol. 87(10), 805–812 (2009).
   Google Scholar
• Suzuki Inoue K, Inoue O, Ozaki Y. [Identification of the novel platelet activation receptor CLEC-2 and Its pathological and physiological roles]. Rinsho. Byori. 58(12), 1193–1202 (2010).
   Google Scholar
• Watson SP, Herbert JM, Pollitt AY. GPVI and CLEC-2 in hemostasis and vascular integrity. J. Thromb. Haemost. 8(7), 1456–1467 (2010).
   PubMed Web of Science ®Google Scholar
• Parguiña AF, Alonso J, Rosa I et al. A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: implications for CLEC-2 signaling regulation. Blood 120(26), e117–e126 (2012).
   PubMed Web of Science ®Google Scholar
• Lee H, Hamilton JR. Physiology, pharmacology, and therapeutic potential of protease-activated receptors in vascular disease. Pharmacol. Ther. 134(2), 246–259 (2012).
   Google Scholar
• De Candia E. Mechanisms of platelet activation by thrombin: a short history. Thromb. Res. 129(3), 250–256 (2012).
   PubMed Web of Science ®Google Scholar
• Murugappan S, Shankar H, Bhamidipati S, Dorsam RT, Jin J, Kunapuli SP. Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKCdelta in platelets. Blood 106(2), 550–557 (2005).
   PubMed Web of Science ®Google Scholar
• Maguire PB, Wynne KJ, Harney DF, O'Donoghue NM, Stephens G, Fitzgerald DJ. Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics 2(6), 642–648 (2002).
   PubMed Web of Science ®Google Scholar
• Jones ML, Shawe-Taylor AJ, Williams CM, Poole AW. Characterization of a novel focal adhesion kinase inhibitor in human platelets. Biochem. Biophys. Res. Commun. 389(1), 198–203 (2009).
   PubMed Web of Science ®Google Scholar
• Garcia A, Prabhakar S, Hughan S et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood 103(6), 2088–2095 (2004).
   PubMed Web of Science ®Google Scholar
• Ma P, Cierniewska A, Signarvic R et al. A newly identified complex of spinophilin and the tyrosine phosphatase, SHP-1, modulates platelet activation by regulating G protein-dependent signaling. Blood 119(8), 1935–1945 (2012).
   PubMed Web of Science ®Google Scholar
• Tucker KL, Kaiser WJ, Bergeron AL et al. Proteomic analysis of resting and thrombin-stimulated platelets reveals the translocation and functional relevance of HIP-55 in platelets. Proteomics 9(18), 4340–4354 (2009).
   PubMed Web of Science ®Google Scholar
• Han J, Shui JW, Zhang X, Zheng B, Han S, Tan TH. HIP-55 is important for T-cell proliferation, cytokine production, and immune responses. Mol. Cell Biol. 25(16), 6869–6878 (2005).
   PubMed Web of Science ®Google Scholar
• Cimmino G, Golino P. Platelet Biology and Receptor Pathways. J. Cardiovasc. Transl. Res. 6(3), 299–309 (2013).
   PubMed Web of Science ®Google Scholar
• Hechler B, Gachet C. P2 receptors and platelet function. Purinergic Signal 7(3), 293–303 (2011).
   PubMed Web of Science ®Google Scholar
• Tello-Montoliu A, Jover E, Rivera J, Valdes M, Angiolillo DJ, Marin F. New perspectives in antiplatelet therapy. Curr. Med. Chem. 19(3), 406–427 (2012).
   PubMedGoogle Scholar
• Hattori M, Gouaux E. Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature 485(7397), 207–212 (2012).
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Varga-Szabo D, Elvers M. Integrins in platelet activation. J. Thromb. Haemost. 7(Suppl. 1), 206–209 (2009).
   PubMed Web of Science ®Google Scholar
• Bennett JS, Berger BW, Billings PC. The structure and function of platelet integrins. J. Thromb. Haemost. 7(Suppl. 1), 200–205 (2009).
   PubMed Web of Science ®Google Scholar
• Takagi J. Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins. Biochem. Soc. Trans. 32(Pt3), 403–406 (2004).
   PubMed Web of Science ®Google Scholar
• Qureshi AH, Chaoji V, Maiguel D et al. Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling. PLoS One 4(10), e7627 (2009).
   PubMed Web of Science ®Google Scholar
• Kirk RI, Sanderson MR, Lerea KM. Threonine phosphorylation of the beta 3 integrin cytoplasmic tail, at a site recognized by PDK1 and Akt/PKB in vitro, regulates Shc binding. J. Biol. Chem. 275(40), 30901–30906 (2000).
   PubMed Web of Science ®Google Scholar
• Sato K, Nagao T, Kakumoto M et al. Adaptor protein Shc is an isoform-specific direct activator of the tyrosine kinase c-Src. J. Biol. Chem. 277(33), 29568–29576 (2002).
   PubMedGoogle Scholar
• Senis YA, Antrobus R, Severin S et al. Proteomic analysis of integrin alphaIIbbeta3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions. J. Thromb. Haemost. 7(10), 1718–1726 (2009).
   PubMed Web of Science ®Google Scholar
• Rex S, Beaulieu LM, Perlman DH et al. Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release. Thromb. Haemost. 102(1), 97–110 (2009).
   PubMedGoogle Scholar
• Mateos-Caceres PJ, Macaya C, Azcona L et al. Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients. Thromb. Haemost. 103(1), 160–170 (2010).
   PubMed Web of Science ®Google Scholar
• Cheng Z, Sundberg-Smith LJ, Mangiante LE et al. Focal adhesion kinase regulates smooth muscle cell recruitment to the developing vasculature. Arterioscler Thromb. Vasc. Biol. 31(10), 2193–2202 (2011).
   Google Scholar
• Nossaman BD, Kadowitz PJ. Stimulators of soluble guanylyl cyclase: future clinical indications. Ochsner. J. 13(1), 147–156 (2013).
   Google Scholar
• Pena E, Padro T, Molins B, Vilahur G, Badimon L. Proteomic signature of thrombin-activated platelets after in vivo nitric oxide-donor treatment: coordinated inhibition of signaling (phosphatidylinositol 3-kinase-gamma, 14-3-3zeta, and growth factor receptor-bound protein 2) and cytoskeleton protein translocation. Arterioscler. Thromb. Vasc. Biol. 31(11), 2560–2569 (2011).
   PubMed Web of Science ®Google Scholar
• Parguiña AF, Grigorian-Shamajian L, Agra RM et al. Proteins involved in platelet signaling are differentially regulated in acute coronary syndrome: a proteomic study. PLoS One 5(10), e13404 (2011).
   Google Scholar
• Hohenester E, Sasaki T, Giudici C, Farndale RW, Bachinger HP. Structural basis of sequence-specific collagen recognition by SPARC. Proc. Natl Acad. Sci. USA 105(47), 18273–18277 (2008).
   PubMed Web of Science ®Google Scholar
• Parguiña AF, Grigorian-Shamagian L, Agra RM et al. Variations in platelet proteins associated with ST-elevation myocardial infarction: novel clues on pathways underlying platelet activation in acute coronary syndromes. Arterioscler Thromb. Vasc. Biol. 31(12), 2957–2964 (2011).
   PubMed Web of Science ®Google Scholar
• Froebel J, Cadeddu RP, Hartwig S et al. Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes. Mol. Cell Proteomics 12(5), 1272–1280 (2013).
   Google Scholar
• Kanaji T, Ware J, Okamura T, Newman PJ. GPIbalpha regulates platelet size by controlling the subcellular localization of filamin. Blood 119(12), 2906–2913 (2012).
   PubMed Web of Science ®Google Scholar
• Maurer-Spurej E, Devine DV. Platelet aggregation is not initiated by platelet shape change. Lab. Invest. 81(11), 1517–1525 (2001).
   Google Scholar
• Burkhart JM, Vaudel M, Gambaryan S et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 120(15), e73–e82 (2012).
   PubMed Web of Science ®Google Scholar
• Senis Y, Garcia A. Platelet proteomics: state of the art and future perspective. Methods Mol. Biol. 788, 367–399 (2012).
   Google Scholar
• Boyanova D, Nilla S, Birschmann I, Dandekar T, Dittrich M. PlateletWeb: a systems biologic analysis of signaling networks in human platelets. Blood 119(3), e22–e34 (2012).
   PubMedGoogle Scholar